Condition Lookup
Category:
Other Cardiovascular Conditions
Number of Conditions: 20
Familial Hypercholesterolemia
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Dyslipidemia
Symptoms:
tendon xanthomas; xanthelasmas (yellow deposits around the eyes); corneal arcus (gray-white ring around the cornea); premature cardiovascular disease
Root Cause:
Genetic mutation (commonly in the LDLR, APOB, or PCSK9 genes) leading to impaired clearance of LDL cholesterol, resulting in extremely high LDL levels.
How it's Diagnosed: videos
Lipid panel showing LDL >190 mg/dL (in adults) or >160 mg/dL (in children), family history of early cardiovascular disease, and genetic testing.
Treatment:
Aggressive LDL-lowering therapy, often starting at a young age. Lifestyle changes and combination medications are used.
Medications:
High-potency statins (e.g., atorvastatin , rosuvastatin ), ezetimibe , PCSK9 inhibitors (e.g., evolocumab , alirocumab ), bile acid sequestrants, and LDL apheresis in severe cases.
Prevalence:
How common the health condition is within a specific population.
Heterozygous familial hypercholesterolemia affects 1 in 250 people; homozygous form is rarer (1 in 1 million).
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history of early cardiovascular disease; inheritance of a mutation in LDLR, APOB, or PCSK9 genes
Prognosis:
The expected outcome or course of the condition over time.
Treatable but requires lifelong management; untreated cases lead to early cardiovascular events.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Coronary artery disease; myocardial infarction; stroke; aortic stenosis
Myxoma
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Heart Tumors
Symptoms:
shortness of breath; chest pain; palpitations; syncope (fainting); systemic embolism (stroke or arterial blockage); fever; fatigue
Root Cause:
A benign tumor originating in the heart, most commonly in the left atrium, attached to the interatrial septum.
How it's Diagnosed: videos
Diagnosed via echocardiography or cardiac MRI.
Treatment:
Treated with surgical resection.
Medications:
No specific medications treat myxoma itself; anticoagulants (e.g., warfarin ) may be used to prevent embolic events if indicated.
Prevalence:
How common the health condition is within a specific population.
Rare, with an estimated prevalence of 0.5 per million people per year.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Sporadic in most cases; familial forms may occur in Carney complex (a genetic syndrome).
Prognosis:
The expected outcome or course of the condition over time.
Excellent with surgical removal; recurrence is rare but possible in familial cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Embolic events (stroke, organ infarction), valve obstruction, arrhythmias, sudden death.
Rhabdomyoma
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Dyslipidemia
Symptoms:
heart murmurs; arrhythmias; heart failure; shortness of breath; cyanosis in severe cases
Root Cause:
A benign tumor of the heart muscle, often associated with tuberous sclerosis.
How it's Diagnosed: videos
Diagnosed with echocardiography or MRI, often in infants or children.
Treatment:
Treatment may not be required as many regress spontaneously, but surgery is needed if symptomatic.
Medications:
Everolimus (an mTOR inhibitor) may reduce tumor size in tuberous sclerosis-associated rhabdomyomas.
Prevalence:
How common the health condition is within a specific population.
Rare, with most cases occurring in infants and children.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Tuberous sclerosis (genetic disorder).
Prognosis:
The expected outcome or course of the condition over time.
Good; many regress spontaneously. Symptomatic cases improve after surgery.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Obstructed blood flow, arrhythmias, heart failure.
Metastatic Tumors to the Heart
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Dyslipidemia
Symptoms:
shortness of breath; chest pain; arrhythmias; heart failure symptoms; pericardial effusion (fluid around the heart)
Root Cause:
Secondary invasion of the heart by cancers such as lung, breast, or melanoma.
How it's Diagnosed: videos
Diagnosed through imaging like echocardiography, CT, or MRI, and biopsy if needed.
Treatment:
Treatment focuses on palliative care, chemotherapy, or radiation for the primary cancer.
Medications:
Depends on the primary cancer type (e.g., platinum-based chemotherapy for lung cancer).
Prevalence:
How common the health condition is within a specific population.
More common than primary cardiac tumors; seen in advanced cancer cases.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Advanced-stage cancer, aggressive malignancies, hematogenous spread.
Prognosis:
The expected outcome or course of the condition over time.
Poor, due to advanced disease.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Heart failure, tamponade, arrhythmias.
Cardiogenic Shock
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Shock Syndromes
Symptoms:
hypotension; cold, clammy skin; altered mental status; weak pulse; reduced urine output; shortness of breath
Root Cause:
Severe pump failure, often due to myocardial infarction (heart attack) or advanced heart failure.
How it's Diagnosed: videos
Diagnosed by clinical signs, echocardiography, and hemodynamic monitoring.
Treatment:
Treated with inotropes, mechanical support (e.g., intra-aortic balloon pump), and addressing the underlying cause.
Medications:
Vasopressors (e.g., norepinephrine ), inotropes (e.g., dobutamine ), and diuretics if pulmonary congestion is present.
Prevalence:
How common the health condition is within a specific population.
Occurs in about 5–10% of acute myocardial infarctions.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Acute MI, heart failure, myocarditis, cardiomyopathy.
Prognosis:
The expected outcome or course of the condition over time.
High mortality (~40–50%) even with treatment.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Multi-organ failure, death.
Hypovolemic Shock
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Shock Syndromes
Symptoms:
hypotension; tachycardia; pale, cool skin; reduced urine output; altered mental status
Root Cause:
Severe blood or fluid loss leading to inadequate perfusion.
How it's Diagnosed: videos
Diagnosed via clinical signs and laboratory tests indicating blood/fluid loss.
Treatment:
Treated with fluid resuscitation, blood transfusion, and addressing the source of bleeding or fluid loss.
Medications:
No direct medications; supportive treatments include vasopressors (e.g., norepinephrine ) if fluids are insufficient.
Prevalence:
How common the health condition is within a specific population.
Common in trauma or gastrointestinal bleeding.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Trauma, surgery, severe burns, dehydration.
Prognosis:
The expected outcome or course of the condition over time.
Variable, depending on the severity and rapidity of treatment.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Organ failure, death.
Septic Shock
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Shock Syndromes
Symptoms:
fever; low blood pressure; tachycardia; altered mental status; warm or cold skin depending on phase
Root Cause:
Systemic infection leading to widespread inflammation, vasodilation, and cardiovascular collapse.
How it's Diagnosed: videos
Diagnosed by clinical signs, elevated lactate, and infection markers.
Treatment:
Treated with intravenous fluids, antibiotics, vasopressors, and source control.
Medications:
Broad-spectrum antibiotics (e.g., piperacillin-tazobactam), vasopressors (e.g., norepinephrine ), corticosteroids (if refractory).
Prevalence:
How common the health condition is within a specific population.
Affects 20–30 million people annually worldwide; high in ICUs.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Immunosuppression, chronic illness, invasive devices, severe infections.
Prognosis:
The expected outcome or course of the condition over time.
High mortality (20–50%), depending on timely treatment.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Multi-organ failure, death.
Obstructive Shock
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Shock Syndromes
Symptoms:
severe hypotension; shortness of breath; distended neck veins; cold extremities
Root Cause:
Physical obstruction to blood flow (e.g., pulmonary embolism, cardiac tamponade).
How it's Diagnosed: videos
Diagnosed by imaging (e.g., echocardiography or CT) to identify obstruction.
Treatment:
Treated by relieving the obstruction (e.g., thrombolysis for pulmonary embolism, pericardiocentesis for tamponade).
Medications:
Thrombolytics (e.g., alteplase ) for pulmonary embolism; vasopressors may stabilize hemodynamics.
Prevalence:
How common the health condition is within a specific population.
Less common than other shock types; associated with specific conditions.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Pulmonary embolism, trauma, malignancy, pericarditis.
Prognosis:
The expected outcome or course of the condition over time.
Variable, depending on the cause and promptness of treatment.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Multi-organ failure, death.
Post-Myocardial Infarction Syndrome (Dressler Syndrome)
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Post-Surgical/Cardiac Intervention Complications
Symptoms:
chest pain (pleuritic in nature); fever; pericardial friction rub; fatigue; malaise
Root Cause:
An immune-mediated inflammatory response to myocardial injury, involving the pericardium, pleura, or both.
How it's Diagnosed: videos
Based on clinical presentation (chest pain and fever), echocardiography (to identify pericardial effusion), and elevated inflammatory markers (ESR, CRP). Rule out other causes of fever or chest pain following a myocardial infarction.
Treatment:
Anti-inflammatory medications and supportive care.
Medications:
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen , corticosteroids like prednisone (if NSAIDs are ineffective or contraindicated), and colchicine to reduce recurrence risk.
Prevalence:
How common the health condition is within a specific population.
Occurs in about 1-5% of patients after a myocardial infarction.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Recent myocardial infarction, history of pericarditis, autoimmune disorders.
Prognosis:
The expected outcome or course of the condition over time.
Generally good with treatment; symptoms resolve in most cases without long-term complications.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic pericarditis, large pericardial effusion leading to tamponade, recurrence of symptoms.
Complications of Heart Valve Surgery
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Post-Surgical/Cardiac Intervention Complications
Symptoms:
fever; fatigue; shortness of breath; chest pain; arrhythmias; swelling in legs; wound infection symptoms (redness, discharge)
Root Cause:
Complications can arise from mechanical valve malfunction, infection (endocarditis), or issues related to prosthetic valve placement (e.g., thrombosis, structural degeneration).
How it's Diagnosed: videos
Echocardiography (TTE or TEE), blood cultures (for infections), imaging studies (e.g., CT for paravalvular leaks), and clinical symptoms.
Treatment:
Treatment depends on the complication.
Medications:
Antibiotics for infection (e.g., vancomycin , ceftriaxone ); anticoagulants like warfarin or direct oral anticoagulants (DOACs) for thromboembolism; diuretics or antiarrhythmic drugs for heart failure or arrhythmias.
Prevalence:
How common the health condition is within a specific population.
Varies depending on the type of valve and procedure; prosthetic valve endocarditis occurs in 1-6% of cases, while mechanical valve thrombosis is less frequent.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Older age, diabetes, poor surgical technique, previous infections, inadequate anticoagulation.
Prognosis:
The expected outcome or course of the condition over time.
Good with appropriate treatment but varies by complication; prosthetic valve endocarditis can have a high mortality rate if untreated.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Infection (endocarditis), valve dysfunction (stenosis or regurgitation), paravalvular leaks, thromboembolism, arrhythmias, bleeding from anticoagulation.
Complications of Pacemakers or ICDs
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Post-Surgical/Cardiac Intervention Complications
Symptoms:
localized swelling or pain at the device site; fever (infection); hiccups (diaphragmatic stimulation); arrhythmias; fatigue; dizziness
Root Cause:
Mechanical or infectious issues, lead displacement, inappropriate shocks, or device failure.
How it's Diagnosed: videos
Chest X-ray or fluoroscopy (to check lead position), echocardiography (to assess device-related complications like effusion), device interrogation, and blood cultures (if infection is suspected).
Treatment:
Lead repositioning, device reprogramming, antibiotics for infections, or surgical revision for mechanical issues.
Medications:
Antibiotics like vancomycin or cefazolin for device infections; antiarrhythmics for arrhythmias related to the device; anticoagulants for thromboembolism prevention if leads are inappropriately positioned.
Prevalence:
How common the health condition is within a specific population.
Complication rates vary, with infection occurring in about 1-2% of cases, and lead displacement in up to 5% of new implants.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Older age, diabetes, immunosuppression, poor surgical technique, prior device infections.
Prognosis:
The expected outcome or course of the condition over time.
Most complications can be managed effectively; however, infections involving the device require prompt intervention to prevent serious outcomes.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Lead displacement, device infection, cardiac perforation, inappropriate shocks, systemic infections like sepsis.
Complications of Coronary Artery Bypass Graft Surgery
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Post-Surgical/Cardiac Intervention Complications
Symptoms:
chest pain; shortness of breath; fever (infection); arrhythmias; leg pain or swelling (if graft is from the leg)
Root Cause:
Complications may arise from graft failure, wound infections, arrhythmias, or stroke during or after the surgery.
How it's Diagnosed: videos
Angiography (to assess graft patency), blood cultures (for infections), imaging studies (CT or ultrasound), and echocardiography.
Treatment:
Depends on the complication.
Medications:
Aspirin and P2Y12 inhibitors (e.g., clopidogrel ) to prevent graft thrombosis; antibiotics for infections; beta-blockers or amiodarone for arrhythmias; statins to manage cholesterol.
Prevalence:
How common the health condition is within a specific population.
Major complications occur in about 5-12% of patients, with infection rates around 1-2% and graft failure rates around 10% within the first year.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Older age, diabetes, obesity, smoking, poor graft selection, and poor perioperative care.
Prognosis:
The expected outcome or course of the condition over time.
Generally good with successful surgery, but long-term outcomes depend on the patient's adherence to lifestyle changes and medications.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Graft occlusion, infection (sternal or leg wound), atrial fibrillation, heart attack, stroke.
Stent Thrombosis
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Post-Surgical/Cardiac Intervention Complications
Symptoms:
sudden chest pain; shortness of breath; heart attack symptoms (e.g., diaphoresis, nausea); fainting
Root Cause:
Blood clot formation within a coronary stent, leading to partial or complete obstruction of the coronary artery.
How it's Diagnosed: videos
Coronary angiography confirms the presence of a clot in the stent; elevated cardiac biomarkers (troponin) support myocardial injury.
Treatment:
Emergency percutaneous coronary intervention (PCI) to restore blood flow; thrombolytic therapy in some cases.
Medications:
Dual antiplatelet therapy (DAPT) with aspirin and P2Y12 inhibitors (e.g., clopidogrel , ticagrelor , or prasugrel ); anticoagulants like heparin during PCI.
Prevalence:
How common the health condition is within a specific population.
Rare, occurring in approximately 0.5-1% of patients after stent placement.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Premature discontinuation of antiplatelet therapy, suboptimal stent placement, diabetes, smoking, and acute coronary syndrome at presentation.
Prognosis:
The expected outcome or course of the condition over time.
Poor if untreated, as it often leads to myocardial infarction or death; better outcomes with prompt revascularization.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Myocardial infarction, heart failure, arrhythmias, death.
Cardiac Amyloidosis
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Metabolic and Genetic Cardiovascular Disorders
Symptoms:
shortness of breath; swelling in legs and feet (edema); fatigue; irregular heartbeat; difficulty exercising; low blood pressure; chest pain
Root Cause:
Deposition of amyloid protein in the heart, leading to stiffened heart walls and impaired heart function.
How it's Diagnosed: videos
Echocardiography, cardiac MRI, endomyocardial biopsy, blood tests (e.g., serum free light chain assay), and imaging with technetium-labeled radiotracers. Genetic testing may be performed for hereditary forms.
Treatment:
Includes addressing heart failure symptoms, halting amyloid protein deposition, and organ transplantation in advanced cases.
Medications:
Tafamidis (stabilizes transthyretin amyloid proteins), diuretics (e.g., furosemide , to manage fluid buildup), and anticoagulants (e.g., warfarin , if atrial fibrillation is present). Tafamidis is a transthyretin stabilizer; diuretics are used for symptom management, and anticoagulants prevent blood clots.
Prevalence:
How common the health condition is within a specific population.
Rare; transthyretin amyloidosis (ATTR) affects approximately 1 in 100,000 people, with higher prevalence in older adults and certain populations.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Advanced age, male sex, African or Mediterranean ancestry, family history of amyloidosis, chronic inflammatory diseases.
Prognosis:
The expected outcome or course of the condition over time.
Variable; depends on the type and extent of amyloidosis. Prognosis improves with early diagnosis and treatment. Without treatment, progression leads to heart failure and poor outcomes.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Heart failure, arrhythmias, thromboembolism, sudden cardiac death.
Hemochromatosis-Related Cardiomyopathy
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Metabolic and Genetic Cardiovascular Disorders
Symptoms:
fatigue; shortness of breath; chest pain; palpitations; edema in legs; irregular heartbeat; signs of heart failure
Root Cause:
Excessive iron deposition in the heart muscle, leading to oxidative damage, fibrosis, and impaired heart function.
How it's Diagnosed: videos
Blood tests (serum ferritin, transferrin saturation), genetic testing (HFE gene mutations), cardiac MRI (to assess iron overload), echocardiography, and liver biopsy (to confirm systemic iron overload).
Treatment:
Iron removal through phlebotomy or chelation therapy, and management of heart failure symptoms.
Medications:
Deferoxamine , deferasirox , or deferiprone (iron chelators). These are used to reduce iron overload in patients who cannot undergo phlebotomy. Diuretics and beta-blockers may also be used to manage heart failure symptoms.
Prevalence:
How common the health condition is within a specific population.
Hemochromatosis affects approximately 1 in 200–300 individuals of European descent; cardiomyopathy develops in a subset of untreated cases.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Genetic predisposition (HFE gene mutations), male sex, excessive alcohol consumption, metabolic syndrome.
Prognosis:
The expected outcome or course of the condition over time.
Good if diagnosed and treated early; untreated cases can lead to severe heart failure and other organ damage.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Heart failure, arrhythmias, liver cirrhosis, diabetes, hypogonadism.
Fabry Disease
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Metabolic and Genetic Cardiovascular Disorders
Symptoms:
pain in hands and feet; decreased sweating; heat and cold intolerance; fatigue; angiokeratomas (dark skin spots); proteinuria; shortness of breath; cardiomyopathy; arrhythmias
Root Cause:
X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to deficient alpha-galactosidase A activity and accumulation of globotriaosylceramide (GL3/Gb3) in tissues, including the heart.
How it's Diagnosed: videos
Enzyme assay (alpha-galactosidase A activity), genetic testing (GLA mutation), urine tests (for GL3 levels), echocardiography, cardiac MRI, and biopsy.
Treatment:
Enzyme replacement therapy (ERT) or chaperone therapy, supportive care for symptoms, and management of cardiac and renal complications.
Medications:
Agalsidase alfa or beta (enzyme replacement therapy), migalastat (chaperone therapy). Diuretics and ACE inhibitors are used for heart and kidney complications, respectively. ERT replaces deficient enzymes; migalastat stabilizes mutant enzymes in eligible patients.
Prevalence:
How common the health condition is within a specific population.
Rare, estimated at 1 in 40,000 to 1 in 60,000 males; females can be carriers or mildly symptomatic.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history, X-linked inheritance (affects males more severely).
Prognosis:
The expected outcome or course of the condition over time.
Improved with early diagnosis and treatment. Untreated cases may lead to progressive kidney failure, heart disease, and stroke.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Hypertrophic cardiomyopathy, arrhythmias, stroke, kidney failure.
Pompe Disease
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Metabolic and Genetic Cardiovascular Disorders
Symptoms:
muscle weakness; difficulty breathing; enlarged heart (in infantile-onset); fatigue; exercise intolerance; respiratory failure
Root Cause:
Autosomal recessive lysosomal storage disorder caused by mutations in the GAA gene, resulting in deficient acid alpha-glucosidase enzyme and glycogen accumulation in tissues, including the heart and skeletal muscles.
How it's Diagnosed: videos
Enzyme assay (acid alpha-glucosidase activity), genetic testing (GAA mutation), muscle biopsy, and imaging studies (e.g., echocardiography in infantile-onset cases).
Treatment:
Enzyme replacement therapy (ERT) and supportive care, including respiratory support and physical therapy.
Medications:
Alglucosidase alfa (enzyme replacement therapy). ERT replaces the deficient enzyme to reduce glycogen accumulation in tissues. Additional medications may include bronchodilators and oxygen for respiratory support.
Prevalence:
How common the health condition is within a specific population.
Estimated at 1 in 40,000 births globally; varies by population and ethnicity.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Genetic predisposition (autosomal recessive inheritance), family history.
Prognosis:
The expected outcome or course of the condition over time.
Variable; infantile-onset cases have poor outcomes without treatment, but ERT significantly improves survival and quality of life. Late-onset cases progress more slowly.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure, heart failure (in infantile-onset), severe disability due to muscle weakness.
Obesity-Related Cardiovascular Disease
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Lifestyle-Related and Functional Disorders
Symptoms:
shortness of breath during exertion; chest discomfort; fatigue; swelling in extremities (edema); high blood pressure
Root Cause:
Excess body fat contributes to systemic inflammation, insulin resistance, and increased cardiac workload, leading to conditions like heart failure, hypertension, and coronary artery disease.
How it's Diagnosed: videos
Body mass index (BMI ≥30), waist-to-hip ratio, clinical evaluation of cardiovascular health (e.g., echocardiogram, ECG, lipid panel, blood pressure monitoring).
Treatment:
Weight loss via lifestyle changes, bariatric surgery for severe cases, and management of cardiovascular complications (e.g., hypertension, hyperlipidemia).
Medications:
Weight-loss medications (e.g., orlistat , liraglutide ); statins for cholesterol (e.g., rosuvastatin ); antihypertensives (e.g., beta-blockers like metoprolol ).
Prevalence:
How common the health condition is within a specific population.
Affects approximately 40% of adults in high-income countries, with obesity contributing significantly to the global burden of cardiovascular disease.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Poor diet, physical inactivity, genetic predisposition, socioeconomic status, and comorbid conditions like diabetes.
Prognosis:
The expected outcome or course of the condition over time.
Improvement is possible with significant weight loss and treatment of related conditions; untreated obesity increases the risk of heart attack, stroke, and premature death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Coronary artery disease, heart failure, atrial fibrillation, venous thromboembolism, and stroke.
Cardiac Syndrome X (Microvascular Angina)
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Lifestyle-Related and Functional Disorders
Symptoms:
chest pain during physical or emotional stress; fatigue; shortness of breath; chest tightness without coronary artery blockages
Root Cause:
Impaired blood flow in the coronary microvasculature due to endothelial dysfunction or increased sensitivity to stimuli, without significant large coronary artery blockages.
How it's Diagnosed: videos
Exclusion of coronary artery disease via angiography; stress testing; coronary flow reserve measurement using imaging like PET or cardiac MRI.
Treatment:
Symptom management with lifestyle changes, medications, and stress reduction techniques.
Medications:
Beta-blockers (e.g., atenolol ) to reduce heart workload, calcium channel blockers (e.g., diltiazem ) to improve blood flow, and nitrates (e.g., nitroglycerin ) for angina relief. Antiplatelets (e.g., aspirin ) may be considered.
Prevalence:
How common the health condition is within a specific population.
Affects approximately 2-4% of patients undergoing angiography for chest pain, more common in women than men.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Female sex (postmenopausal), hypertension, diabetes, obesity, smoking, and chronic stress.
Prognosis:
The expected outcome or course of the condition over time.
Good prognosis as it’s not usually associated with myocardial infarction; symptoms can be persistent but manageable.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic angina, reduced quality of life, and potential overlap with other cardiovascular conditions.
Deconditioning (from Prolonged Inactivity)
Specialty: Cardiovascular
Category: Other Cardiovascular Conditions
Sub-category: Lifestyle-Related and Functional Disorders
Symptoms:
fatigue; reduced exercise tolerance; shortness of breath; muscle weakness; lightheadedness
Root Cause:
Loss of cardiovascular and muscular efficiency due to prolonged physical inactivity, leading to reduced cardiac output, muscle atrophy, and orthostatic intolerance.
How it's Diagnosed: videos
Clinical evaluation; exercise stress testing; assessment of muscle strength and endurance; postural vital sign measurements (e.g., orthostatic hypotension).
Treatment:
Gradual reconditioning with supervised exercise programs (e.g., aerobic and resistance training), physical therapy, and dietary optimization.
Medications:
Medications are typically not necessary unless treating underlying conditions such as orthostatic hypotension (e.g., midodrine ) or cardiac issues (e.g., beta-blockers).
Prevalence:
How common the health condition is within a specific population.
Common in individuals with prolonged hospitalization, chronic illness, or sedentary lifestyles; prevalence increases with age.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Bed rest, chronic illness, aging, sedentary lifestyle, prolonged recovery after injury or surgery.
Prognosis:
The expected outcome or course of the condition over time.
Full recovery is possible with proper rehabilitation; untreated deconditioning can lead to chronic fatigue, frailty, and cardiovascular decline.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Increased risk of falls, cardiovascular decompensation, and prolonged recovery from illness or surgery.